What is he best known for?
The fields of study he is best known for:
- Gene
- DNA
- Internal medicine
His primary areas of study are Cell biology, Molecular biology, Cell adhesion molecule, Endothelial stem cell and Biochemistry.
His Cell biology study combines topics in areas such as Integrin, Cell adhesion and Binding site.
His research in Molecular biology intersects with topics in Antigen, Complementary DNA, Peptide sequence, Protein structure and Oligonucleotide.
The concepts of his Cell adhesion molecule study are interwoven with issues in Neural cell adhesion molecule and Cell junction.
His studies in Endothelial stem cell integrate themes in fields like Receptor, CD31 and Pathology.
His Biochemistry study frequently draws connections between related disciplines such as Platelet.
His most cited work include:
- PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily (870 citations)
- Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. (639 citations)
- The biology of PECAM-1. (616 citations)
What are the main themes of his work throughout his whole career to date?
Peter J. Newman mostly deals with Cell biology, Platelet, Molecular biology, Biochemistry and Immunology.
His Cell biology research is multidisciplinary, relying on both Endothelial stem cell, Integrin and Cell adhesion.
He works mostly in the field of Endothelial stem cell, limiting it down to concerns involving CD31 and, occasionally, Inflammation.
Peter J. Newman has researched Platelet in several fields, including Receptor and Glycoprotein.
His Molecular biology study also includes fields such as
- Epitope, which have a strong connection to Polyclonal antibodies,
- Antibody together with Recombinant DNA.
His work carried out in the field of Immunology brings together such families of science as In vivo and Neonatal alloimmune thrombocytopenia.
He most often published in these fields:
- Cell biology (55.74%)
- Platelet (42.21%)
- Molecular biology (36.89%)
What were the highlights of his more recent work (between 2011-2020)?
- Cell biology (55.74%)
- Platelet (42.21%)
- Immunology (20.08%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cell biology, Platelet, Immunology, Molecular biology and Neonatal alloimmune thrombocytopenia.
His Cell biology research is multidisciplinary, incorporating elements of Endothelial stem cell, Receptor, Biochemistry, Cell junction and Cell adhesion.
His Cell adhesion research is multidisciplinary, incorporating perspectives in Vasculogenesis and CD31.
His biological study spans a wide range of topics, including Integrin and Induced pluripotent stem cell.
The various areas that he examines in his Molecular biology study include Plasmid, Membrane anchoring and Platelet transfusion refractoriness.
His Neonatal alloimmune thrombocytopenia study also includes
- Fetus and Protein subunit most often made with reference to Antibody,
- Epitope which connect with Platelet membrane glycoprotein, CRISPR and Human platelet antigen.
Between 2011 and 2020, his most popular works were:
- PECAM-1: regulator of endothelial junctional integrity. (155 citations)
- Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31) (139 citations)
- Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration. (78 citations)
In his most recent research, the most cited papers focused on:
- Gene
- DNA
- Internal medicine
Peter J. Newman mainly focuses on Cell biology, Endothelial stem cell, Platelet, Vascular permeability and Cell adhesion.
His study in Cell biology is interdisciplinary in nature, drawing from both HEK 293 cells and Cell junction.
His study connects Cell adhesion molecule and Cell junction.
His Platelet study is concerned with the field of Immunology as a whole.
His Immunology research integrates issues from Molecular biology and Neonatal alloimmune thrombocytopenia.
His Vascular permeability research includes elements of Barrier function and CD31.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
